MedPath

COMPARISON OF MARMA THERAPY AND MUKTA VATI IN THE TREATMENT OF STAGE I HYPERTENSIO

Not Applicable
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Registration Number
CTRI/2020/07/026313
Lead Sponsor
Rishikul campus UAU hardwar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with be enrolled with 1 hypertension (130-139/80-89 mmhg)

Hypertensive patients who are drug naive

Normal LV function

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ormalize the BP 120/80mmhgTimepoint: 3 months
Secondary Outcome Measures
NameTimeMethod
Relieve in symptomsTimepoint: 3 months
© Copyright 2025. All Rights Reserved by MedPath